In this study, we developed novel mouse models for t(8;21) AML using RUNX1-ETO9a, Trp53 (the mouse homolog of TP53)-deficient mice and Cas9 knockin mice. This evidence concerns the gene RUNX1 and acute myeloid leukemia.